According to official website, the General Administration of Market Supervision recently announced the "Iron Fist" action to investigate and deal with cases in the field of people's livelihood in 221.
Typical case (the fourth batch), in which "Guangzhou Tianhe District Market Supervision Bureau investigated and dealt with the advertisement of illegal toxic drugs for medical use issued by Guangzhou Meisheng Medical Beauty Clinic Co., Ltd." was listed as one of the typical cases.
The case shows that in the early stage, Tianhe District Market Supervision Bureau received a report that Guangzhou Meisheng Medical Beauty Clinic Co., Ltd. was suspected of publishing illegal advertisements for face-lifting needles through online stores, and the law enforcement officers of Tianhe District Market Supervision Bureau immediately conducted on-site inspections on the company.
after investigation, the party concerned opened the "DR REBORN medical beauty flagship store" to sell medical beauty projects through the Internet in February 22. In the project of selling "DR REBORN's domestic face-lifting needle to remove wrinkles and improve the beauty of masseter's small V-face face-lifting needle and leg-lifting needle", an advertisement involving "domestic face-lifting needle" and "Hengli face-lifting needle" was released, and its face-lifting needle was actually "botulinum toxin A for Hengli brand injection".
according to the notice on the inclusion of botulinum toxin type a in the management of toxic drugs (No.45 [28] of the State Food and Drug Administration), botulinum toxin type A has been included in the management of toxic drugs. Modern Advertising found that in 28, the Ministry of Health and the State Food and Drug Administration (SFDA) jointly issued the Notice on the Inclusion of Botulinum Toxin A in the Management of Toxic Drugs, which included Botulinum Toxin A and its preparations in the management of toxic drugs, and stipulated that pharmaceutical wholesale enterprises could only sell Botulinum Toxin A preparations to medical institutions, and pharmaceutical retail enterprises were not allowed to buy or sell Botulinum Toxin A preparations. Units and individuals that illegally produce, manage and use botulinum toxin A shall be severely punished according to law.
The illegal advertisement of toxic drugs for medical use by the parties concerned violates the provisions of the first paragraph of Article 15 of the Advertising Law of the People's Republic of China. Article 15 of the Advertising Law stipulates that special drugs such as narcotic drugs, psychotropic drugs, toxic drugs for medical use, radioactive drugs, pharmaceutical precursor chemicals, and drugs, medical devices and treatment methods for drug rehabilitation shall not be advertised. Prescription drugs other than those specified in the preceding paragraph can only be advertised in medical and pharmaceutical professional journals designated by the health administrative department of the State Council and the drug supervision and administration department of the State Council.
Tianhe District Market Supervision Bureau ordered the parties concerned to stop publishing false and illegal advertisements and imposed administrative penalties on them according to law. On May 2, 221, Guangzhou Tianhe District Market Supervision Bureau imposed an administrative penalty of 2, yuan on Guangzhou Meisheng Medical Beauty Clinic Co., Ltd. for publishing advertisements of toxic drugs for medical use.
The General Administration of Market Supervision said that special drugs such as toxic drugs, narcotic drugs, psychotropic drugs and radioactive drugs for medical use are necessary in medical activities on the one hand, and proper use is conducive to treating diseases and relieving patients' suffering; On the other hand, it is potentially harmful. Once it is improperly used, it may lead to addiction, damage health and even endanger life safety, and it should be strictly managed. The market supervision department will severely investigate and punish the advertising behavior of releasing such special drugs according to law, and maintain the order of the advertising market.